AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 76.3% in January

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 23,366 shares, an increase of 76.3% from the December 31st total of 13,256 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an average trading volume of 28,413 shares, the short-interest ratio is presently 0.8 days. Based on an average trading volume of 28,413 shares, the short-interest ratio is presently 0.8 days. Approximately 0.6% of the shares of the stock are short sold.

AquaBounty Technologies Stock Performance

Shares of AQB stock opened at $0.91 on Friday. The firm has a market capitalization of $3.53 million, a price-to-earnings ratio of -1.10 and a beta of 1.24. AquaBounty Technologies has a one year low of $0.50 and a one year high of $2.95. The company has a 50 day moving average price of $0.95 and a 200 day moving average price of $1.12.

AquaBounty Technologies (NASDAQ:AQB) last released its quarterly earnings data on Tuesday, October 28th. The company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.62) by $0.26.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Institutional Trading of AquaBounty Technologies

An institutional investor recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP acquired a new stake in AquaBounty Technologies, Inc. (NASDAQ:AQB) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned 0.97% of AquaBounty Technologies at the end of the most recent reporting period. 8.92% of the stock is owned by hedge funds and other institutional investors.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.